Jazz Pharmaceuticals PLC (JAZZ) SEC Filings — 2025
19 SEC filings for Jazz Pharmaceuticals PLC (JAZZ) in 2025.
Filings
- Jazz Pharmaceuticals Files 8-K — 8-K · Nov 17, 2025
- Jazz Pharma Swings to Loss on Soaring R&D Costs, Revenue Up — 10-Q · Nov 5, 2025
- Jazz Pharmaceuticals Announces Executive and Board Changes — 8-K · Oct 28, 2025
- Jazz Pharmaceuticals Files 8-K Report — 8-K · Oct 22, 2025
- Jazz Pharma Q2 Revenue Dips Slightly to $950M Amidst Stable Product Sales — 10-Q · Aug 6, 2025
- Jazz Pharmaceuticals Files 8-K on Financials — 8-K · Aug 5, 2025
- Jazz Pharmaceuticals Schedules Shareholder Vote — 8-K · Jul 25, 2025
- Jazz Pharmaceuticals Files Definitive Proxy Materials — DEFA14A · Jul 14, 2025
- Jazz Pharma Announces Executive Changes — 8-K · Jul 10, 2025
- Jazz Pharma Sets July 24 AGM, Focuses on Governance — DEF 14A · Jun 6, 2025
- Jazz Pharma Q1 2025 Sales Dip — 10-Q · May 7, 2025
- Jazz Pharmaceuticals Files 8-K on Financials — 8-K · May 6, 2025
- Jazz Pharmaceuticals Files 2024 Annual Report Amendment — 10-K/A · Apr 25, 2025
- Jazz Pharmaceuticals Files 8-K Report — 8-K · Apr 21, 2025
- Jazz Pharmaceuticals Enters Material Definitive Agreement — 8-K · Apr 8, 2025
- Jazz Pharmaceuticals Files 8-K Amendment — 8-K/A · Mar 5, 2025
- Jazz Pharmaceuticals plc Files 2024 10-K — 10-K · Feb 26, 2025
- Jazz Pharmaceuticals Files 8-K on Financials — 8-K · Feb 25, 2025
- Jazz Pharmaceuticals Files 8-K — 8-K · Jan 13, 2025